Observational studyFrontiers in endocrinology2026
Fertility and endocrinopathies among adults with β-thalassemia major treated at Dubai thalassemia center.
Observational study in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: β-thalassemia major (BTM) is made up of group of quantitative anemias characterized by severe anemia and hemochromatosis from frequent blood transfusion. Iron overload in the endocrine system (pituitary gland, thyroid and parathyroid glands, pancreas, and gonads) resulting in different endocrinopathies is a major challenge among BTM patients especially among adults. This study aims at describing different endocrinopathies; namely short stature, hypothyroidism and diabetes mellitus among adults treated at Dubai Thalassemia Center in United Arab Emirates. Materials and methods: This study is observational retrospective cohort in nature, of all adult patients with BTM aged above 18 years who attended the Dubai Thalassemia Centre during the period of November 2019 and May 2021, were extracted from patients' electronic medical records. Results: A total of 200 adults with BTM above 18 years of age were enrolled in this study. Females constituted 54.5% (n=109) of the sample while 45.5% (n=91) were males. The annual average pre-transfusion hemoglobin level was 9 gm/dL in 81.5%, n=163, while it was low (<9 gm/dL) in 18.0% (n=36) patients. The mean height of all male patients was 165.4 cm (SD = 6.05) and for females it was 154.11 cm (SD = 5.67), while the mean weights of all male and female patients were 60.4 kg (SD + 12.74) and 55.8 kg (SD = 14.60), respectively. Of all female patients, the mean age of menarche was 15 years. The prevalence of Hypogonadism is 23%, Diabetes Mellitus 15%, Hypothyroidism 11%, Hypoparathyroidism 9% and Short Stature 1.5%. Conclusion: Despite the improved care and introduction of oral chelators, the prevalence of endocrinopathies namely hypogonadism, short stature, hypothyroidism, hypoparathyroidism and diabetes mellitus still pose a major concern for patients with BTM. More emphasis needs to be placed on improving compliance with chelation, and further studies are required to investigate new therapies options to reduce these complications.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.